Research Briefs

Medicine · Surgery

Esophageal Cancer Research and Treatment

Log in to follow
Abstract editorial illustration accompanying the article: Trial reports outcomes after local rectal surgery following chemoradiotherapy
Health & Medicine
Moderate evidenceHuman study

Trial reports outcomes after local rectal surgery following chemoradiotherapy

A prospective, multicenter phase II trial examined whether removing only the treated tumor area through the anus could preserve the rectum in people with locally advanced rectal cancer who responded well to chemoradiotherapy. Among 80 participants, three-year disease-free survival was 84.8%, and local recurrence occurred in 5.0% during the reported follow-up. Because everyone received local excision and there was no comparison group, the findings do not establish that this approach is as effective as more extensive surgery.

·39 views
Abstract editorial illustration accompanying the article: Review examines targeted immune-cell treatments in stomach and junction cancers
Health & Medicine
High evidenceReview

Review examines targeted immune-cell treatments in stomach and junction cancers

This systematic review examined seven early-phase human studies of treatments directed at the CLDN18.2 protein in gastric and gastroesophageal-junction cancers. Across 396 mostly previously treated patients, the studies reported tumor responses and frequent but generally low-grade cytokine release syndrome; the researchers said the results need confirmation in randomized trials.

·73 views
Abstract editorial illustration accompanying the article: Review suggests chemotherapy may improve overall survival in esophageal cancer
Health & Medicine
Moderate evidenceReview

Review suggests chemotherapy may improve overall survival in esophageal cancer

This review analyzed human studies comparing two treatments given before surgery for locally advanced esophageal or esophagogastric junction adenocarcinoma: FLOT chemotherapy and CROSS chemoradiotherapy. The pooled estimate favored FLOT for overall survival, but the groups had similar three-year survival, tumor response, surgical margins, and several major perioperative outcomes.

·58 views